Tags

Type your tag names separated by a space and hit enter

Belimumab in systemic lupus erythematosus -- what can be learned from longterm observational studies?
J Rheumatol. 2014 Feb; 41(2):192-3.JR

Authors+Show Affiliations

Department of Clinical Sciences, Rheumatology, University Hospital Lund, Lund 22185, Sweden.

Pub Type(s)

Editorial
Comment

Language

eng

PubMed ID

24488851

Citation

Bengtsson, Anders A.. "Belimumab in Systemic Lupus Erythematosus -- what Can Be Learned From Longterm Observational Studies?" The Journal of Rheumatology, vol. 41, no. 2, 2014, pp. 192-3.
Bengtsson AA. Belimumab in systemic lupus erythematosus -- what can be learned from longterm observational studies? J Rheumatol. 2014;41(2):192-3.
Bengtsson, A. A. (2014). Belimumab in systemic lupus erythematosus -- what can be learned from longterm observational studies? The Journal of Rheumatology, 41(2), 192-3. https://doi.org/10.3899/jrheum.131378
Bengtsson AA. Belimumab in Systemic Lupus Erythematosus -- what Can Be Learned From Longterm Observational Studies. J Rheumatol. 2014;41(2):192-3. PubMed PMID: 24488851.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Belimumab in systemic lupus erythematosus -- what can be learned from longterm observational studies? A1 - Bengtsson,Anders A, PY - 2014/2/4/entrez PY - 2014/2/4/pubmed PY - 2014/10/1/medline SP - 192 EP - 3 JF - The Journal of rheumatology JO - J. Rheumatol. VL - 41 IS - 2 SN - 0315-162X UR - https://www.unboundmedicine.com/medline/citation/24488851/Belimumab_in_systemic_lupus_erythematosus____what_can_be_learned_from_longterm_observational_studies L2 - http://www.jrheum.org/cgi/pmidlookup?view=long&pmid=24488851 DB - PRIME DP - Unbound Medicine ER -